1. Armah IB. Contribution of presynaptic ?2 adrenoceptor stimulation to the antihypertensive action of moxonidine. J Cardiovasc Pharmacol 1987;10(Suppl 4):581?583.
2. Armah IB, Hofferber E, Stenzel W. General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Arzneimittelforschung/Drug Res 1988;38(II),10:1426?1434.
3. Armah IB. Unique presynaptic ?2-receptor selectivity and specifity of the antihypertensive agent moxonidine. Arzneimittelforschung/Drug Res 1988;38(II),10:1435?1442.
4. Bergerhausen J. Moxonidine (BE 5895), a full agonist at human platelet ?2 adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 1985;329(Suppl):R80.
5. Ernsberger P. Moxonidine, a second generation centrally-acting antihypertensive, binds selectively to imidazoline sites in the ventrolateral medulla (VLM) and kidney. Pharmacologist 1990;52:191.